| 0.00% |
| 4 | STATE STREET CORP | 832K | $68.9M | +7.8% | 3.658% | 0.00% |
| 5 | TANG CAPITAL MANAGEMENT LLC | 708K | $58.6M | 0.0% | 3.112% | 2.66% |
| 6 | DIMENSIONAL FUND ADVISORS LP | 623K | $51.6M | +17.4% | 2.742% | 0.01% |
| 7 | AMERICAN CENTURY COMPANIES INC | 574K | $47.6M | +199.9% | 2.527% | 0.02% |
| 8 | ARROWSTREET CAPITAL, LIMITED PARTNERSHIP | 562K | $46.5M | -0.4% | 2.472% | 0.02% |
| 9 | Global Alpha Capital Management Ltd. | 558K | $46.2M | +54.5% | 2.454% | 2.77% |
| 10 | GEODE CAPITAL MANAGEMENT, LLC | 536K | $44.4M | +9.7% | 2.359% | 0.00% |
| 11 | MILLENNIUM MANAGEMENT LLC | 507K | $42.0M | -14.3% | 2.231% | 0.02% |
| 12 | Nuveen, LLC | 415K | $34.4M | +3.1% | 1.826% | 0.01% |
| 13 | VANGUARD PORTFOLIO MANAGEMENT LLC | 407K | $33.7M | +8.3% | 1.792% | 0.00% |
| 14 | Ranger Investment Management, L.P. | 343K | $28.4M | -4.7% | 1.509% | 1.80% |
| 15 | DEUTSCHE BANK AG\ | 323K | $26.8M | +1.2% | 1.423% | 0.01% |
| 16 | Invesco Ltd. | 309K | $25.6M | -4.7% | 1.360% | 0.00% |
| 17 | UBS Group AG | 298K | $24.6M | -40.2% | 1.309% | 0.00% |
| 18 | KENNEDY CAPITAL MANAGEMENT LLC | 296K | $24.5M | +0.7% | 1.302% | 0.43% |
| 19 | AMERIPRISE FINANCIAL INC | 287K | $23.8M | +6.3% | 1.264% | 0.00% |
| 20 | NOMURA ASSET MANAGEMENT INTERNATIONAL INC. | 287K | $23.8M | -0.1% | 1.263% | 0.04% |
| 21 | Ikarian Capital, LLC | 272K | $22.5M | -8.4% | 1.197% | 2.43% |
| 22 | Aberdeen Group plc | 272K | $22.5M | +31.8% | 1.195% | 0.03% |
| 23 | OBERWEIS ASSET MANAGEMENT INC/ | 265K | $22.0M | +19.8% | 1.167% | 0.45% |
| 24 | WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC | 258K | $21.4M | -21.1% | 1.136% | 0.06% |
| 25 | Rubric Capital Management LP | 258K | $21.4M | — | 1.135% | 0.20% |
denotes a marquee investor (Buffett, Burry, ARK, Tiger Global, Pershing Square, Baupost and other widely-followed managers). “% of Fund” shows how much of that investor’s total 13F portfolio is invested in ANIP — a direct measure of their conviction.
| 93.04% |
| +0.46 pp |
| $1.25B |
| +27% |
| Q4 2024 | 203 | 1.9% | 92.58% | +1.28 pp | $984M | 7.3% |
| Q3 2024 | 207 | — | 91.30% | — | $1.06B | — |
Source: SEC 13F institutional filings. Ownership % requires market cap data and will show once linked. Δ columns compare to the immediately prior filed quarter.
44 institutions opened new positions in ANIP during Q2 2026, while 25 fully exited. 196 added to existing positions and 53 trimmed.
ANIP institutional ownership fell by 5.61 percentage points quarter-over-quarter, with a net change of +21 holders.
The top 10 institutions account for 40.1% of all reported 13F value in ANIP, and the top 25 account for 61.4%.
All data is sourced from SEC Form 13F filings, which institutional investment managers with at least $100M in assets are required to file each quarter. We process every 13F filing from EDGAR and recompute the aggregates after each cycle. Insider transactions are sourced from Form 4 filings.
ANI Pharmaceuticals, Inc. (ANIP) Institutional Ownership